Pomerantz LLP announces that a class action lawsuit has been filed against Lion Biotechnologies, Inc. (“Lion” or the “Company”) (NASDAQ:LBIO) and certain of its officers. The class action, filed in United States District Court, Northern District of California, and docketed under 17-cv-02188 is on behalf of a class consisting of investors who purchased or otherwise …